Logo image of SMX

SMX SECURITY MATTERS PLC (SMX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SMX - IE000TB5RTG4 - Common Stock

135.82 USD
-196.16 (-59.09%)
Last: 12/8/2025, 7:03:57 PM
141.43 USD
+5.61 (+4.13%)
After Hours: 12/8/2025, 7:03:57 PM
Fundamental Rating

0

Overall SMX gets a fundamental rating of 0 out of 10. We evaluated SMX against 125 industry peers in the Electronic Equipment, Instruments & Components industry. SMX has a bad profitability rating. Also its financial health evaluation is rather negative. SMX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year SMX has reported negative net income.
SMX had a negative operating cash flow in the past year.
SMX Yearly Net Income VS EBIT VS OCF VS FCFSMX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of SMX (-53.75%) is worse than 83.20% of its industry peers.
SMX has a worse Return On Equity (-1536.66%) than 96.00% of its industry peers.
Industry RankSector Rank
ROA -53.75%
ROE -1536.66%
ROIC N/A
ROA(3y)-14.79%
ROA(5y)N/A
ROE(3y)-62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SMX Yearly ROA, ROE, ROICSMX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

SMX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SMX Yearly Profit, Operating, Gross MarginsSMX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

0

2. Health

2.1 Basic Checks

SMX has more shares outstanding than it did 1 year ago.
SMX has a worse debt/assets ratio than last year.
SMX Yearly Shares OutstandingSMX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 1M 2M 3M
SMX Yearly Total Debt VS Total AssetsSMX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

SMX has an Altman-Z score of 0.06. This is a bad value and indicates that SMX is not financially healthy and even has some risk of bankruptcy.
SMX has a Altman-Z score of 0.06. This is in the lower half of the industry: SMX underperforms 78.40% of its industry peers.
A Debt/Equity ratio of 5.56 is on the high side and indicates that SMX has dependencies on debt financing.
SMX has a Debt to Equity ratio of 5.56. This is amonst the worse of the industry: SMX underperforms 96.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.56
Debt/FCF N/A
Altman-Z 0.06
ROIC/WACCN/A
WACCN/A
SMX Yearly LT Debt VS Equity VS FCFSMX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.08 indicates that SMX may have some problems paying its short term obligations.
With a Current ratio value of 0.08, SMX is not doing good in the industry: 98.40% of the companies in the same industry are doing better.
A Quick Ratio of 0.08 indicates that SMX may have some problems paying its short term obligations.
SMX's Quick ratio of 0.08 is on the low side compared to the rest of the industry. SMX is outperformed by 98.40% of its industry peers.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
SMX Yearly Current Assets VS Current LiabilitesSMX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M 20M

0

3. Growth

3.1 Past

The earnings per share for SMX have decreased strongly by -191272441.41% in the last year.
EPS 1Y (TTM)-191272441.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.77%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

SMX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SMX Price Earnings VS Forward Price EarningsSMX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SMX Per share dataSMX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2M -4M -6M -8M -10M

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SMX!.
Industry RankSector Rank
Dividend Yield N/A

SMX SECURITY MATTERS PLC

NASDAQ:SMX (12/8/2025, 7:03:57 PM)

After market: 141.43 +5.61 (+4.13%)

135.82

-196.16 (-59.09%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.03%
Inst Owner Change-97.52%
Ins Owners2.35%
Ins Owner ChangeN/A
Market Cap142.61M
Revenue(TTM)N/A
Net Income(TTM)-20.91M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 104.78
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-10921662.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-10.43
FCFYN/A
OCF(TTM)-10.4
OCFYN/A
SpS0
BVpS1.3
TBVpS-33.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -53.75%
ROE -1536.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-14.79%
ROA(5y)N/A
ROE(3y)-62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 5.56
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.54%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z 0.06
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-191272441.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-125.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1102.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1100.33%
OCF growth 3YN/A
OCF growth 5YN/A

SMX SECURITY MATTERS PLC / SMX FAQ

What is the fundamental rating for SMX stock?

ChartMill assigns a fundamental rating of 0 / 10 to SMX.


Can you provide the valuation status for SMX SECURITY MATTERS PLC?

ChartMill assigns a valuation rating of 0 / 10 to SMX SECURITY MATTERS PLC (SMX). This can be considered as Overvalued.


What is the profitability of SMX stock?

SMX SECURITY MATTERS PLC (SMX) has a profitability rating of 0 / 10.


How financially healthy is SMX SECURITY MATTERS PLC?

The financial health rating of SMX SECURITY MATTERS PLC (SMX) is 0 / 10.